Cargando…

Relapse of neuromyelitis optica associated with oral progestin

Detalles Bibliográficos
Autores principales:	Li, Li-Min, Zhang, Chao, Zhang, Lin-Jie, Guo, Hui-Yue, Yang, Chun-Sheng, Zhang, Rui, Li, Yu-Jing, Shi, Fu-Dong, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Postscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031264/ https://www.ncbi.nlm.nih.gov/pubmed/28993474 http://dx.doi.org/10.1136/jnnp-2017-316356

Ejemplares similares

Low body mass index can be associated with the risk and poor outcomes of neuromyelitis optica with aquaporin-4 immunoglobulin G in women
por: Baek, Seol-Hee, et al.
Publicado: (2018)

Naïve B cells followed by aquaporin-4 antibodies characterise the onset of neuromyelitis optica: evidence from stem cell transplantation
por: McNaughton, Peter, et al.
Publicado: (2022)

Neuromyelitis optica spectrum disorders with and without connective tissue disorders
por: Yang, Chun-Sheng, et al.
Publicado: (2018)

Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
por: Shu, Yaqing, et al.
Publicado: (2016)

Subregional structural and connectivity damage in the visual cortex in neuromyelitis optica
por: Cai, Huanhuan, et al.
Publicado: (2017)

Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody
por: Wang, Liang, et al.
Publicado: (2022)

Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders
por: Zhang, Shanchao, et al.
Publicado: (2022)

Sleep abnormality in neuromyelitis optica spectrum disorder
por: Song, Yijun, et al.
Publicado: (2015)

Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
por: Fan, Moli, et al.
Publicado: (2020)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Six-month follow-up of gut microbiota richness in patients with COVID-19
por: Chen, Yanfei, et al.
Publicado: (2022)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

Muscle damage in patients with neuromyelitis optica spectrum disorder
por: Chen, Hong-xi, et al.
Publicado: (2017)

Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder
por: Li, Ting, et al.
Publicado: (2021)

Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
por: Uzawa, Akiyuki, et al.
Publicado: (2011)

Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability
por: Zhang, Xue, et al.
Publicado: (2018)

Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder
por: Rao, Jie, et al.
Publicado: (2022)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum Disorders
por: Tian, De-Cai, et al.
Publicado: (2020)

Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders
por: Shi, Lili, et al.
Publicado: (2023)

Paroxysmal Chorea as a Relapse of Myelopathy in a Patient with Neuromyelitis Optica
por: Lee, Sang-Soo, et al.
Publicado: (2009)

Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016)

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)

Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice
por: Li, Zhiguo, et al.
Publicado: (2018)

Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica
por: Yang, Chunsheng, et al.
Publicado: (2019)

Neuromyelitis optica spectrum disorders without and with autoimmune diseases
por: Zhang, Bingjun, et al.
Publicado: (2014)

Editorial: Advances in neuromyelitis optica spectrum disorders
por: Cai, Yu, et al.
Publicado: (2022)

Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants
por: Li, Fang, et al.
Publicado: (2020)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
por: Dogonowski, Anne-Marie, et al.
Publicado: (2016)

Keratocystoma of the parotid gland: case report and immunohistochemical investigation
por: Zhang, Mei-Fang, et al.
Publicado: (2010)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Chen, Hai, et al.
Publicado: (2016)

Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Sun, Jie, et al.
Publicado: (2023)

Containing an Account of the Discovery of the Composition of Muriatic Acid
por: Pacchioni,
Publicado: (1805)

Postscript to The History of the European Bone and Joint Infection Society
por: McNally, Martin
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r7ed7g6ubqaisgjfo3jbvt231r